Iproniazid or iproniazide

This classification denotes an antidepressive agent and monoamine oxidase inhibitor with the molecular formula C9H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D892HFI3XA, chemically known as 4-pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide but generally known as iproniazid, which bears US NIH Compound Identifier 3748. European Medicines Agency schedules Iproniazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08283MIG. IPRONIAZID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iproniazid under HS 29333910 and SITC 51574. As of Q4 2014, IPRONIAZID remains the US FDA Preferred Term for this commodity. Iproniazid bears US NLM identifiers UMLS ID C0022059 and NCI Concept Code C97714. SMILES: O=C(NNC(C)C)c1ccncc1.